SmartAction Teams Up with NFL QB Jameis Winston and Dr. Scott Kelley for Coronavirus Self-Assessment

LOS ANGELES, April 9, 2020 /PRNewswire/ — SmartAction®, a leading provider of AI-powered Virtual Agents for contact centers, today announced it has teamed up with NFL QB Jameis Winston and Dr. Scott Kelley to combat coronavirus misinformation by establishing a national COVID-19 hotline.

“With the lack of resources and misinformation out there, Dr. Kelley and I wanted to create a toll-free national hotline to give every family rapid responses and peace of mind from the safety of their own home,” said Jameis Winston.

SmartAction donated its Rapid Response Virtual Agent and associated services to the cause, and delivered the end-to-end solution in less than a week.

By calling the toll-free hotline, (844) 837-8268 or (844) TEST-COVID, callers can interact with SmartAction’s AI-powered virtual agent to have their questions and concerns about the virus answered immediately, self-assess through a set of triage questions, and receive guidance on further medical treatment and/or a coronavirus test.

“The very reason we built our Rapid Response Virtual Agent was to provide organizations the ability to use AI to answer commonly asked questions, screen callers for those who need human assistance, and provide an escalation path. We couldn’t be happier to put it to use to combat COVID-19 with Jameis Winston and Dr. Scott Kelley,” said Gary Davis, President, SmartAction.

Davis continued, “Since typical development cycles for voice applications can be extended due to building grammars and training models, we devised a channel-switching approach in times of crisis when a robust solution needs to be in-production without delay.”

For a limited time, SmartAction is providing its Rapid Response Virtual Agent to organizations in need without any upfront fees or professional services related to customization or integration.

For more on SmartAction’s Rapid Response Virtual Agent, visit https://www.smartaction.ai/smartaction-rapid-response-virtual-agent/

For COVID-19 related questions or screening, call 844-8378-26843 (TEST-COVID).

About SmartAction

We are SmartAction®, the contact center industry’s undisputed leader in purpose-built AI-powered Virtual Agents for customer service. At SmartAction, we utilize powerful technology and thoughtful CX services to deliver frictionless conversational AI experiences over voice, chat, and text. As a result, our clients are able to free up their live agents to handle higher priority conversations. But don’t take our word for it – ask our CX-obsessed clients including AAA, DSW, Electrolux, and Choice Hotels, whose reviews rank SmartAction as the #1 Virtual Agent provider on Gartner Peer Insights.

Related Links
www.smartaction.ai

Media Contact
Marlyn Arenas
marlyn.arenas@smartaction.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/smartaction-teams-up-with-nfl-qb-jameis-winston-and-dr-scott-kelley-for-coronavirus-self-assessment-301038055.html

SOURCE SmartAction

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

1 hour ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

4 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

4 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

4 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

4 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

4 hours ago